Hypertension is often labeled a "silent killer," but it rarely acts alone. Managing high blood pressure effectively requires looking past the cuff to assess secondary target-organ damage and complex metabolic comorbidities like diabetes and chronic inflammation.
This World Hypertension Day, Goldsite Diagnostics highlights the critical importance of a multi-marker diagnostic approach. By arming clinicians with rapid, accurate point-of-care and laboratory diagnostics, we enable early intervention and comprehensive cardiovascular risk profiling.
The Interplay of Hypertension, Diabetes, and Inflammation
Hypertension and diabetes frequently coexist, compounding a patient’s risk for stroke and cardiovascular mortality. Concurrently, persistent systemic inflammation accelerates endothelial dysfunction and plaque instability. Routine screening of HbA1c alongside specific protein biomarkers offers clinicians a clearer, multi-dimensional view of cardiovascular vulnerability.
A single blood pressure reading tells only part of the story. Tracking glycemic control via HbA1c and vascular strain through key biomarkers transforms standard hypertensive management into precise, preventative care.
Goldsite's Targeted Diagnostic Solutions
GSH-60
Automated HPLC HbA1c Analyzer
- Gold standard High-Performance Liquid Chromatography (HPLC)
- Rapid turnaround time of just 60 seconds per test
- High throughput handling up to 110 samples automatically
- Dual sampling modes supporting both whole blood and capillary blood
- Flawless precision with a variant detection feature to ensure reliable readings
Perfect for high-volume settings looking to screen metabolic syndromes and monitor chronic diabetic pathways linked to progressive hypertension.
GPP-100 / Aristo
Specific Protein Solutions for Vascular Risk
- Versatile deployment options from compact POCT (GPP-100) to fully automated (Aristo) systems
- Precise, rapid assays for hs-CRP, D-Dimer, and Cystatin C
- Streamlined cartridge and reagent handling requiring minimal operator hands-on time
- Minimal sample volumes ideal for sensitive or geriatric patients
Essential for evaluating baseline vascular inflammation, thromboembolic tendencies, and early-stage hypertensive renal deterioration.
Elevating the Standard of Hypertensive Care
- Proactive Comorbidity Mapping: Rapid verification of glycemic status using the GSH-60 prevents overlooked diabetic-hypertensive complications.
- Vascular Risk Stratification: Early alerts through highly sensitive markers like hs-CRP and D-Dimer allow for preemptive therapeutic adjustments before acute events occur.
- Optimized Clinical Flow: From automated laboratory workflows to instantaneous point-of-care results, medical teams save valuable time.
- End-to-End Care Integration: A unified approach means patients spend less time waiting and receive more customized, proactive counseling.
True cardiovascular protection reaches far beyond monitoring blood pressure.
This World Hypertension Day, Goldsite stands with healthcare pioneers globally,
delivering the clarity needed to protect hearts and save lives.
About Goldsite Diagnostics
Established in 1999 and headquartered in Shenzhen, China, Goldsite Diagnostics Inc. is a leading manufacturer of in vitro diagnostic (IVD) products. We specialize in developing innovative, high-quality instruments and reagents — from POCT to fully automatic analyzers — trusted by healthcare professionals in over 100 countries. Our mission is to deliver accurate diagnostics that empower better care for every patient.